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•

Introduction

•

Even before the discovery that genes were encoded on DNA and
the subsequent discovery of the double-helical structure of DNA, the
question of how we inherit our traits has been studied. Hippocrates, a
Greek physician c.a. 400 B.C., was the first to propose a model of how
traits are inherited.1 Since that time, many discoveries have fleshed out
our understanding of how genes are regulated to form a pattern of
inheritance. We now understand DNA is compacted through a
mechanism involving histones, which are basic proteins containing a
great number of modifiable residues. DNA wraps around a nucleosome
core particle, which is an octamer formed with two of each of the histone
proteins: H2A, H2B, H3, and H4 (Figure A-1a).2
The level of DNA compaction fluctuates between a
Figure A-1:
(a) The structure of the nucleosome core particle
as taken from Luger, K. et al. (1997). Nature
398, 251-260.

transcriptionally
silenced
heterochromatin
state and a
transcriptionally
active
euchromatin
state (Figure A1b;
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(b) Chromatin compaction occurs when DNA wraps around histone
proteins.

obtained from http://dellairelab.medicine.dal.ca/images/chromatin.jpg ).3
The exact mechanism by which heterochromatin is interconverted to
euchromatin, and thus which genes are being actively transcribed, is not
fully known.
It is known that covalent modifications on histones play a profound
role in regulating DNA replication, transcription, and heterochromatin
gene silencing. In the subsequent sections, the overarching question to
be addressed is “How are histones, and thus gene transcription,
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regulated?” The first section of the Capstone Project seeks to analyze
this question by asking “How do modifiable histone residues affect
lifespan?” Also, we ask, “Besides their known roles in chromatin biology,
do histones affect cell aging?” The second section analyzes two
proteins, the Mixed Lineage Leukemia (MLL) protein in humans and the
SET1 protein in Saccharomyces cerevisiae, which are involved in
determining the chromatin architecture through the addition of covalent
modifications onto histones. Here, we ask “How do these two proteins
epigenetically regulate transcription by catalyzing the methylation of
lysine 4 of histone H3?” Also, what mechanisms are in place to regulate
their enzymatic activity, and thus chromatin structure?
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•

Chronological Life-Span Analysis of Histone H2B Mutants

•

INTRODUCTION
The mechanism of chromatin modification is central to the
regulation of transcriptional activity.4-5 The fundamental unit is a
nucleosome composed of histones H2A, H2B, H3, and H4 joined in an
octamer. Chromatin, within the eukaryotic genome, is found in two
states; heterochromatin, an inaccessible form which is transcriptionally
repressive, and euchromatin, an accessible form which is
transcriptionally permissive. Conversion between these two states is
regulated by ATP-dependent nucleosome-remodeling complexes which
shift the positions of individual nucleosomes and post-translational
histone modifications that serve to recruit the binding of particular
proteins.6-7
One important model used to analyze how gene expression is
regulated is Saccharomyces cerevisiae, commonly known as baker’s
yeast. Yeast have three silenced regions in their genome: the telomeres,
ribosomal DNA (rDNA), and the silent mating loci (HMR loci).8 By
inserting reporter genes into these silenced regions, screens have been
developed which permit one to identify particular histone mutants that
change a particular silencing phenotype. One screen developed by
Smith and coworkers has a reporter gene for URA3 inserted into the
rDNA regions (Figure B-1).9 When a reporter gene is located within a
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silenced region, the yeast are unable to grow on uracil-deficient plates. If
a particular mutant is able to grow on the URA-deficient plates, it can be
Figure B-1: Representation of the
rDNA structure with location of each
reporter gene. Adapted from Figure
1A in Smith et al. (1999).
Molecular and Cellular Biology.
19 (4): 3184.

concluded that the mutation
has resulted in a loss of rDNA
silencing. Silencing using the
URA3 marker can also be
assayed by growing the yeast
on 5-fluoro-orotic acid (5-FOA)
plates, which is deadly for cells
expressing URA3 (i.e. when
URA3 is not being silenced).10
Although modifications

Figure B-2: Histone H2B mutant library. Conserved lysine and
arginine residues were selected because they are known to be
modifiable amino acids. Boxes indicated residues chosen to be
mutated.
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on histone H3 and H4 have been extensively studied, relatively few
modified sites on histones H2A and H2B are known. Dai and coworkers
have systematically mutated possible modifiable resides on histone H2B
to mimic both the modified and unmodified states (Figure B-2). Further
analysis of these mutations by Dai has shown that there are two arginine
mutants on histone H2B, R95A and R102A (Figure B-3), which play a
Figure B-3: Mapping of R87A and R102A mutants on the yeast
nucleosome core particle.
(a) Surface view of the yeast nucleosome core particle
(Brookhaven PDB [1lD3]. Mutated resides are show in pink.
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(b) Alternate view of the yeast nucleosome core particle (Brookhaven
PDB [1lD3].

(c) Close-up of mutated
resides.
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distinct role in regulating telomeric and rDNA silencing (Junbiao Dai and
Jef Boeke, personal communication). Reference to Figure B-4a is
helpful to determine silencing state based on assays.
The strain containing the R95A H2B mutation grows on uracilFigure B-4:
(a) For each reporter gene, various assays help to determine the
silencing state.

(b) rDNA silencing quantitative growth assay. Ten-fold serial
dilutions of freshly grown yeast cells plated onto either SC
Complete (N/S: Non-selective) or medium containing 5-FOA.
Plates were grown at 30°C for 2 days and then photographed.
Arg95 mutants increase rDNA silencing while R102A mutants
decrease rDNA silencing.
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(b) Telomeric silencing strain: A genetic screen for telomeric
silencing mutants uses the following strain with URA3 and ADE2
reporter genes within the telomeres.

(c) Quantitative growth assay used to determine telomeric silencing.
Ten-fold serial dilutions of freshly grown yeast cells plated onto either
SC Complete (N/S: Non-selective), SC-URA, or medium containing
5-FOA. Plates were grown at 30°C for 2 days and then
photographed.
(d) Quantitative colony color assay used to determine telomeric
silencing. Ten-fold serial dilutions of freshly grown yeast cells plated
onto SC complete media. The colony color was determined after the
plates had been incubated at 30°C for 2 days and then stored at 4°C
for 1 week.

10

deficient plates, suggesting that telomeric silencing was lost (Figure B4d,e). In contrast, rDNA silencing was enhanced in the strain bearing
the R95 H2B mutation (Figure B-4b). Conversely, in the strain bearing
the R102A H2B mutation, rDNA silencing was lost (Figure B-4b) while
telomeric silencing was increased (Figure B-4de). Also, R102A
displayed increased levels of extra-chromosomal rDNA circles, similar to
what was observed when sir2p, a silent information regulator protein
crucial for rDNA silencing, was deleted.11
This finding is significant in that increased accumulation of ERC’s
has been implicated in shorting yeast replicative life span, thus
suggesting that histones are involved in aging.12 The replicative lifespan
is determined by counting the maximum number of buds the mother cell
generates through multiple rounds of cell division.13 After each round of
division, ERCs excise from yeast rDNA repeats and accumulate
asymmetrically in the mother cell.14 Although replicative lifespan is
different from chronological life-span (CLS), which is defined as the
“measure of the length of time a population of yeast organisms remains
viable under non-dividing conditions,”15 it has been suggested that the
mechanisms regulating chronological and replicative lifespan might be
similar.16,17
From the increased levels of ERC’s in H2B R102A strain, it is
likely that replicative lifespan has been shortened. Though both
lifespans have similar mechanisms, this does not suggest that CLS
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should also be shortened. As mentioned earlier, sir2p has also been
found to increase levels of ERCs. However, recent research has begun
to question whether sir2p is involved in aging.18,19 Considering the
distinct roles of H2B residues R95 and R102 in regulating telomeric and
rDNA silencing, the question arises as to whether histones are involved
in aging rather than the regulators of silencing (such as sir2p). We
wished to test that hypothesis and determine whether these mutants
caused any changes in the CLS of yeast.

METHODS
Nucleosome views
Nucleosome views (Figures B-3: a, b, and c) were generated
using PyMOL.20 Yeast nucleosome core particle PDB file 1id3.21
Chronological Lifespan Assay (CLS)
The CLS assay, developed by Fabrizio and Longo, determines the
survival of non-dividing yeast populations under two conditions22. The
first condition is one of high metabolism where the yeast are grown in a
nutrient rich medium (SDC) while the second is a low metabolism
stationary phase which is induced when the yeast are grown in water.
When grown in water, conditions of hyper caloric restriction replicate a
state of extreme starvation found in nature and allow the yeast to survive
longer than in SDC.23
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The following protocol was followed: The strains were streaked
onto YPD plates and allowed to grow for 2 days at 30°C (Figure B-5).
Four colonies per strain
were selected and
independently inoculated
into 2 mL of SDC media
overnight. The overnight
cultures were then diluted
to an OD600 of 0.1 in 20
mL of SDC (day zero).
The 50 mL flasks were
Figure B-5: Schematic representation of
CLS assay. Obtained directly from
Figure One of Parrella, E., and Longo, V.
(2008). Methods 46, 257.

incubated at 30°C with
shaking at 220 rpm. On
day three, two of the SDC

cultures were harvested in sterile Polypropylene tubes by centrifuging at
3000rpm for 5 minutes. The pellet was then resuspended in 20 ml of
sterile water and washed two more times. Then, the cells were
resuspended in 20 ml of water and returned to the original flask.
Subsequently, two 10 µl aliquots per culture (for both SDC and
water cultures) were removed to measure the ability of the yeast to form
a colony (or colony forming units, CFUs). Two aliquots were used per
culture to reduce the variation due to manual error. The aliquots were
serially diluted 1: 10 with sterile water in a 96-well clear flat bottom plate.
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Then 10 µl from the 10-4 dilutions were plated onto YPD plates and were
grown for 2 days (and then counted and imaged). The CFU’s counted
from day three is the initial survival rate (100%). The CFUs were
measured every two days thereafter and lower dilutions were plated as
the mortality rate increased. The experiment continued until survival
reached 1% and a record of the date, dilution factor, the colony count
and the volume spread was made for each plate. From this record, the
number of CFU’s was calculated and plotted against the number of days
elapsed.
RESULTS
The CLS experiment with the histone mutants was repeated two
times. The first time the experiment was attempted, contamination of the
cultures washed with water prevented the completion of the experiment.
Yeast grown in SDC had no contamination, likely due to minimal
manipulation of the yeast. However, the yeast cultures grown in water
had a high risk of contamination due to the washing steps. We then
augmented our experimental design by changing the glassware with
which the cultures were grown. Instead of using 50ml Erlenmeyer flasks,
which make it harder to transfer the cultures into a sterile polypropylene
tube, we grew the cultures in 18mm glass test tubes in rotating drums at
full speed.
As presented before, there are two arginine mutants on histone
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H2B (R95 and R102), which play distinct roles in regulating telomeric
and rDNA silencing. For the experiment, we wanted to test if these
mutants changed the chronological lifespan in yeast. We used two
Figure B-6: Rational for using rim15∆ and sch9∆ as controls in
CLS experiments. Figures are adapted from the graphs found in
Figure 2 of Fabrizio and coworkers (2001) Science 292, 288-290
(a) In previous CLS experiments, rim15∆ has been shown to
greatly reduce lifespan compared to wildtype.

(b) Likewise, sch9 has been shown to greatly extend lifespan
compared to wildtype yeast.
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controls for our experiment, sch9

and rim15 . Sch9

has been

shown in previous experiments to greatly extend CLS, while rim15∆ has
been shown to decrease CLS compared to wild type (Figure B-6 a, b;
adapted from the graphs found in Figure 2 of Fabrizio and coworkers).24
Besides the two positive controls, JDY78 wild type, F7 in strain
JDY78 (R95A), F9 (R102A), and 78-142 (a double mutant of
R95A/R102A) were assayed. Our results can be seen in Figure B-7.
Figure B-7: The following experiment was performed in water (a
state of severe caloric restirction) by switching the cells from SDC to
water after the population reached saturation. R102A was found to
extend lifespan.
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Compared to wild type, both the R95A/R102A double mutant and the
R102A mutant had increased chronological life span. On the other
hand, R95A had no extension of lifespan compared to wild type.
Likewise, R102A had increased lifespan when compared to our long
lived control, sch9 . From this data, we conclude that alanine
substitution of Arg102 greatly extends chronological life span.
DISCUSSION
In the H2B R95A strain, telomeric silencing is lost while the rDNA
silencing is enhanced. In contrast, in the H2B R102A strain, the rDNA
silencing is lost while the telomeric silencing is increased. R102A also
displayed increased levels of extra-chromosomal rDNA circles, similar to
what was observed when histone deacetylase sir2p, a silent information
regulator protein crucial for rDNA, telomeric, and HMR silencing, was
deleted. Because increased levels of ERC’s have been implicated in
decreased replicative lifespan, it would seem that sir2p and thus histones
are involved in aging.
However, recent work has begun to challenge the notion that the
sir2p extends the replicative life-span.25,26 Instead, it has been
suggested that caloric restriction increases lifespan via sch9, which acts
in glucose-dependent signaling and stimulates growth and glycolysis.27,28
It has therefore been questioned whether histones are involved with
aging. We found that R95A did not extend lifespan compared to wild
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type suggesting that the increased CLS of the R95A/R102A double
mutant is likely due to the R102A mutation rather than an effect due to
R95A.
Nevertheless, R102A increased lifespan when compared to
sch9 , which had previously been found to extend lifespan up to three
times when compared to wild-type. It is significant that R102A extended
the lifespan by an amount greater than sch9∆. However, why would
H2B R102A strain increase CLS when the strain was found to increase
accumulation of ERCs that have been implicated in shorting yeast
replicative life span? Though the replicative lifespan and CLS are
regulated similar mechanisms, this does not suggest that a CLS assay
should yield the same result as the replicative lifespan. An example is a
mutation made by Fabrizo and coworkers which decreased CLS, but
extended replicative life span.29
Although it is difficult to understand the mechanism by which
R102A extends lifespan, perhaps the unique profile of decreased rDNA
silencing while increasing telomeric silencing plays a role. Though the
preliminary data ought to be replicated to further support these claims,
we tentatively conclude that alanine substitution of Arg102 greatly
extends chronological life span and suggests that in addition to their
known roles in chromatin biology, histones may, directly or indirectly, be
involved in aging.
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•

Characterization of the Human Mixed Lineage Leukemia
Protein homolog SET1 in Saccharomyces cerevisiae

•

INTRODUCTION
Mixed Lineage Leukemia (MLL) is a protein involved in positively
regulating the transcription of homeobox (HOX) genes, which play
significant roles in animal development and homeostasis. MLL
epigenetically regulates transcription by catalyzing the methylation of
lysine 4 of histone H3, which has been demonstrated to stimulate the
recruitment of chromatin-remodeling factors and histone-modifying
enzymes.30 When MLL is rearranged in human leukemias, deregulated
HOX genes are overexpressed, resulting in aggressive lymphoid and
myeloid acute leukemias.31
Previous work in the Cosgrove lab has made important progress
in understanding the structure and function of MLL in vitro. In particular,
recent experiments in the lab have shown that WDR5 (WD-repeat
protein-5), a member of the conserved core group of proteins that
regulate MLL’s methyltransferase activity, recognizes a conserved motifcalled the “Win” or the WDR5 interaction motif.32 This motif contains a
crucial arginine residue (3765), which is essential for the assembly of the
core complex in vitro (see figure C-133). Furthermore, it has been shown
to be key for MLL’s enzymatic activity.34 The next important step
towards understanding the function of residue R3765 is to understand
the alanine mutation affects how this protein works in vivo.
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Figure C-1: Taken from Figure 1 of Patel et al. (2008). Structure of
WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide*

Saccharomyces cerevisiae, a simple unicellular eukaryote, is a
great model organism with which to study these results in vivo. We will
be looking at MLL’s homolog in yeast, called SET1. Similar to MLL,
SET1 assembles a conserved complex of proteins that regulate histone
methylation and gene expression in yeast.35 Both SET1 and MLL
catalyze the methylation of lysine 4 of histone H3 and when the SET1
gene in S. cerevisiae is deleted, all H3K4 methylation is eliminated. 36,37
While the mechanism for regulating H3K4 methylation is
unknown, two other mutants (besides the R3745) have been identified to
change the methylation state of H3K4 catalyzed by MLL. One of these
mutations is a tyrosine to a phenylalanine at residue 3942 of MLL, which
has been shown to change MLL’s product specificity from primarily being
a monomethyltransferase to a trimethyltransferase.38 The other mutation
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Figure C-2: Expected outcomes for each SET1 mutant. R871A is
the predicted homologous amino acid of R3765A mutant in MLL; like
R3745A, we expect mono-methylation of H3K4 when R871 is
mutated to alanine. The second mutant is Y1052F which we predict
to be homologous to amino acid Y3942 of MLL and is predicted to
change MLL’s product specificity from primarily a
monomethyltransferase to a trimethyltransferase. The third mutation
in SET1 is N1016A which is the predicted homolog of N3906A of
MLL, which we predict to interfere with the binding of the cofactor
SAM, and to abolish the catalytic activity of MLL.

Mutant

Expected
Silencing
phenotype

Expected
euchromatic gene
expression

Expected
H3K4
methylation

R871A

Normal

defective

mono

N1016A

like SET1
knockout

like SET1 knockout

decreased

Y1052F

strong loss of
silencing

increased

trimethylation
everywhere

is N3906A, which interferes with the binding of the cofactor SAM and has
been shown to abolish catalytic activity of MLL.39 The goal of my
research is to biochemically characterize the lysine 4 methylation state of
these three MLL mutants in S. cerevisiae SET1p protein (Figure C-2).

METHODS
Primers for Polymerase Chain Reaction (PCR) and Mutagenesis
Oligonucleotide primers (5’-3’) used:
N1016A forward: GCC CGT TTC AAT GCT CAT TGT TGT GAT CC
N1016A reverse: GGA TCA CAA CAA TGA GCA ATG AAA CGG GC
R871A forward: CAC AAT GAA GCG AAT GAG TAC ACA CC
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R871A reverse: GGT GTG TAC TCA TTC GCT TCA TTG TG
Y1052F forward: GCG AAG AGT TGA CAT TTG ATT ACA
Y1052F reverse: TGT AAT CAA ATG TCA ACT CTT CGC

Plasmids and Mutagenesis
To determine the homologous MLL residues in SET1, a BLAST,
Basic Local Alignment Search Tool, search was conducted. Using this
search, we decided to make the following mutations in SET1: N1016A,
R871A, and Y1056F. The homologous mutations have been shown in
MLL to decrease H3K4 methylation, cause mono-methylation of H3K4,
and cause tri-methylation of H3K4, respectively. The first step was to
make the mutations using Stratagene’s QuikChange® Site-Directed
Mutagenesis Kit.40 Site-directed mutagenesis is a technique that can be
Figure C-3: Schematic
representation of PRS315-SET1
plasmid.

used to create point mutations,
deletions and insertions using a
double-stranded plasmid.
A wild-type PRS315-SET1 plasmid
was obtained from Michael
Cosgrove for the mutagenesis
(Figure C-3). Two oligonucleotide
primers, each being

complementary to the opposite stand of the vector, containing the
mutation were ordered for each mutagenesis (Figure C-441). Upon the
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primers annealing to the plasmid, the strands are extended during a
polymerase chain reaction (PCR) using PfuTurbo DNA polymerase. This
forms unmethylated, mutated plasmids with staggered nicks. After the
PCR reaction, Dpn I is added to digest the methylated parental DNA,
leaving only the mutated vector. This vector is then transformed into
Figure C-4: Schematic representation of site-directed mutagenesis
procedure as adapted from Figure 1 of Stratagene’s QuikChange®
Site-Directed Mutagenesis Kit INSTRUCTION MANUAL.
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Stratagene’s XL1-Blue supercompetent cells and plated onto LBcarbenicillin plates to select for bacteria which have the plasmid.

Plasmid Sequencing

Although ideally the mutagenesis should only result in one
mutation, the entire plasmid must be sequenced to verify that no other
mutations were made. Current fluorescent dye-terminator sequencing
technology allows about 900 nucleotides to be sequenced per
sequencing run. Sequencing technology is a modified PCR reaction. In
each sequencing reaction, besides the vector to be sequenced and DNA
polymerase, four deoxynucleotides (dATP, dGTP, dCTP, and dTTP) are
added to the reaction.42
Sequencing differs from a PCR reaction in that four fluorescently
labeled dideoxynucleotides (ddNTPs) are also added. These ddNTPs
are missing the 3’ hydroxyl group necessary to extend the DNA chain,
therefore terminating the reaction. After the modified PCR reaction is
complete, the resulting DNA strands have different lengths and can be
separated via capillary electrophoresis (see figure C-5a43). Each of the
ddNTPs has a different wavelength at which they fluoresce. Different
nucleotides can then be identified at the end of the capillary by
measuring the wavelength fluoresced upon laser excitation (Figure C5b). From the peaks, a read out of the complementary DNA sequence
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Figure C-5: Fluorescent dye-terminator DNA sequencing
(a) Sequencing technology is a modified PCR reaction containing
the vector to be sequenced, DNA polymerase, four
deoxynucleotides (dATP, dGTP, dCTP, and dTTP), and four
fluorescently labeled dideoxynucleotides (ddNTPs). The
ddNTPs are missing the 3’-OH group necessary to extend the
DNA chain, therefore terminating the reaction. After the
modified PCR reaction is complete, the resulting DNA strands
have different lengths that can be separated via capillary
electrophoresis as they move from a negatively charged buffer
to a positively charged buffer. The fluorescent ddNTPs emit
different wavelengths of fluorescence upon laser excitation
and the measured wavelength is detected and recorded.
From the peaks, a read out of the complementary DNA
sequence is generated and can be compared to the known
sequence of the plasmid insert to verify the mutation. About
900 nucleotides are usually sequenced per run. Figure
adapted from http://dnasequencing.files.wordpress.com/2007/
10/ ce_basic.jpg

(b) Section of DNA chromatograph: The peaks of each color
correspond to a particular labeled nucleotide.
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is generated and can be compared to the known sequence of the
plasmid insert to verify the mutation.
Yeast Strains
Yeast strain JDY137 was used to test rDNA silencing using mHIS3URA3 marker at NTS2; YNB9 with set1∆ (Figure C-6a). Yeast strain
JDY164 was used to test HMR silencing with hmrDA::TRP1 marker;
BY5001 with set1 ∆ (Figure C-6b). Yeast strain JDY165 was used to
test telomeric silencing with URA3 and ADE2 inserted in the telomeric
region, BY5024, also named UCC3505, with set1 ∆ (Figure C-6c). All
strains are selected by growing on synthetic media lacking leucine.

Figure C-6:
(a) Schematic representation of yeast strain JDY137 which was
used to test rDNA silencing using mHIS3-URA3 marker at
NTS2 (YNB9 with set1∆). Adapted from Figure 1A in Smith et
al. (1999). Molecular and Cellular Biology. 19 (4): 3184.
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(b) Representation of strain JDY164 used to test HMR silencing with
hmrDA::TRP1 marker (BY5001 with set1∆).

(c) Schematic representation of strain JDY165 that is used to test
telomeric silencing with URA3 and ADE2 at telomeric region
(BY5024, also named UCC3505, with set1∆).

Silencing Assays
After the three plasmids were sequenced, the plasmids were sent
down to Jef Boeke and Junbiao Dai, our collaborators at Johns Hopkins
Medical Institute to be transformed into yeast set1∆ strains. For each
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Figure C-7: Two independent transformations of each plasmid per
strain. Yeast strain JDY 137 was used to assay rDNA silencing; strain
JDY164 was used to test HMR silencing; strain JDY165 was used to
test telomeric silencing. Note: Each strain is selected by plating onto
SC-LEU plates. Plates were incubated at 30°C for 2 days and then
photographed.

plasmid, two independent transformations per strain were done for three
different yeast set1∆ backgrounds (Figure C-7). Each strain has various
reporter genes which allow the silencing level to be assayed.
The reporters used are URA3, ADE2, TRP1, and mHIS3-URA3.
For strains containing either the URA3 or mHIS3-URA3 reporter genes,
the level of silencing is determined using the following two assays. First,
the yeast are plated onto uracil-deficit plates (SC-URA). When the
URA3 reporter gene is silenced, the yeast are unable to grow. Silencing
using the URA3 marker can also be assayed by growing the yeast on 5fluoro-orotic acid (5-FOA) plates, which is deadly for cells expressing
URA3 (i.e. when URA3 is not being silenced).44
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For strains with the ADE2 reporter genes, if ADE2 is being
silenced, cells build up a chromogenic intermediate that gives the yeast
colonies a red color.45 For cells that are expressing ADE2, the colonies
are white in appearance. Silencing can also be assayed with the TRP1
marker by checking the ability of the yeast to grow on synthetic media
lacking tryptophan (SC-TRP).
After transformation, telomeric, rRNA, and HM loci silencing was
assayed. For each assay, cells were grown overnight at 30°C on a roller
drum at top speed and were diluted to OD600 =1.0. Subsequent ten-fold
serial dilutions were plated onto both non-selective media and selective
media. After the plates were incubated at 30°C for 2 days, photographs
were taken. For telomeric silencing assays using the ADE2 marker, the
colony color was assayed after the plates were incubated at 30°C for 2
days and then stored at 4°C for 1 week.
Figure C-8: For each reporter gene, different assays
can be performed. Silencing level can be determined
from chart below.
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RESULTS
In order to examine if R871A, N1016A, and Y1052F are important
for the function of SET1, they were transformed into three different yeast
set1∆ strains and plated onto selective media for the silencing assays,
as described in Methods: Silencing Assays (refer to Figure C-8 for
interpretation of silencing assays). Our rDNA silencing data suggests
that R871A has approximately the same level of rDNA silencing as the
wild type strain (Figure C-9). N1016A has decreased rDNA silencing,

Figure C-9: rDNA silencing assayed for quantitative growth.
Photographs were taken after 2-3 day incubation at 30°C. assay.
Ten-fold serial dilutions of freshly grown yeast cells plated onto both
SC-LEU (Non-selective for assay; used to check growth of yeast) and
medium containing 5-FOA.
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Figure C-10: HMR silencing assayed for quantitative growth.
Photographs were taken after 2-3 day incubation at 30°C. Tenfold serial dilutions of freshly grown yeast cells plated onto both
SC-LEU and SC-LEU-TRP.

much like the set1∆ strain. Y1052F appears to have increased rDNA
silencing.
On the other hand, our HMR silencing assay data was
unconclusive (Figure C-10). Although one of the R871A transformants
appears to have decreased HMR silencing, the other transformant
appears to have increased HMR silencing. N1016A appears to have
increased silencing, much like set1∆. Y1052F appears have the same
level of silencing as the wildtype. Likewise, our telomeric silencing did
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Figure C-11: Telomeric Silencing Assay: Quantitative colony color
assay used to determine telomeric silencing. Ten-fold serial dilutions
of freshly grown yeast cells plated onto SC complete media. The
colony color was determined after the plates had been incubated at
30°C for 2 days and then stored at 4°C for 1week.

not provide any conclusive results based on the colony color assay
(Figure C-11).

DISCUSSION
When the results were received from our collaborators, most of
the actual silencing phenotypes did not line up with our expected results
(Figure C-12). We then returned to the literature to examine if our
Figure C-12: Expected outcomes for each SET1 mutant and
compared to results.

Mutant

Expected
Silencing
phenotype

Observed
rDNA
silencing

R871A

Normal

Normal

N1016A

Like set1∆

Like set1∆

Y1052F

strong loss of
silencing

Increased
silencing

Observed
HMR
silencing

Observed
Telomeric
silencing

inconclusive

Normal

Like set1∆

Normal

Normal

Normal
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Figure C-13:
(a) Expected rDNA silencing phenotypes for SET1 and set1∆.
Adapted from Figure 1c of Bryk and coworkers (2002).

(b) Observed rDNA silencing phenotype for SET1 and set1∆.

results matched with respect to the different silencing phenotypes
between the set1∆ and the wild type. Previous research by Bryk and
coworkers has shown that SET1 regulates rDNA silencing in yeast.46 In
set1∆ strains, they found that expression of URA3 is approximately 100fold higher than in wild type (Figure C-13a). This result is consistent with
our data for rDNA silencing (Figure C-13b).
Thus, it is possible that our results for the rDNA silencing assay
are valid. Our rDNA silencing data suggested that R871A has
approximately the same level of rDNA silencing as the wild type strain,
which is what we expected if the R871A mutation resulted in monomethylation of H3K4. As expected, N1016A has decreased rDNA
silencing, much like the set1∆ strain. However, we are surprised that
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Y1052F appears to have increased rDNA silencing. We expected
Y1052F to change SET1’s enzymatic activity from a monomethyltransferase to a tri-methyltransferase. Because trimethylation of
H3K4 has been associated with active genes, we expected a loss of
rDNA silencing.
One possible explanation is that SET1 does not significantly
trimethylate rDNA regions. Another hypothesis is that contrary to the
previous model that rDNA silencing requires mono-methylation of H3K4,
perhaps trimethylation is necessary for silencing. These hypotheses
could be tested using rDNA specific H3K4 antibodies for the mono-, di-,
and tri-methylated forms of H3K4 to see if there is a significant increase
in trimethylation. However, it would be best to first verify these results
using a second rDNA silencing assay to ensure the validity of our results.
We also examined the literature concerning telomeric silencing
phenotypes. Nislow and coworkers report that set1∆ mutants are
completely sensitive to 5-FOA, indicating a complete (>100,000 fold)
derepression of URA3 (Figure C-13a).47 We then contacted our
collaborators and asked them to use yeast strain JDY165, which has
markers URA3 and ADE2 at telomeric region, and plate them onto SCLEU+5-FOA. The results of this telomeric silencing assay did not
replicate those reported by Nislow and coworkers (Figure C-13b, Junbiao
Dai, personal communication). Since then, our collaborators have
ordered new primers to check the set1∆ strain to make sure they are
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Figure C-13:
(a) Expected results of telomeric silencing assay. Taken from
Nislow and coworkers Figure 4b (1997).

(b) Observed results of telomeric silencing assay.

correct; and if not, then new set1∆ strains will be made. Therefore, our
project is temporarily on hold until new strains are made.

Future Directions
Currently, we are awaiting news from our collaborators regarding
the set1∆ strains. Once they are received, we would like to proceed with
the biochemical characterization of the three SET1 mutants; N1016A,
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R871A, and Y1052F.

Using antibodies for the mono-, di-, and

trimethylated forms of H3K4, ChIP experiments can be performed to look
specifically for the H3K4 methylation status of genes found in silenced
and euchromatic regions. We expect that N1016A will decrease H3K4
methylation, R871A will lead to mono-methylation of H3K4, and Y1056F
will lead to tri-methylation of H3K4 in the ChIP experiments.
We ultimately hope to discover is whether SET1’s core complex
will assemble in vivo, or will it be unable to assemble in the absence of
the crucial arginine residue in mutant R871A.

Understanding this

question is important because of the involvement of MLL in human
leukemias.

Little is known about MLL’s enzymatic activity as a

methyltransferase, and a greater understanding can aid in identifying
new therapeutic strategies for the treatment of leukemia.

Because

R3765A inhibits the activity of MLL, perhaps new drugs can be made
which block the interaction of MLL and WDR5. Thus, it is important to
understand the regulation of H3K4 methylation both in vitro and in vivo.
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